Hisamitsu Pharmaceutical Co., Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.53 EUR
139.23 M EUR
998.28 M EUR
30.12 M
About Hisamitsu Pharmaceutical Co., Inc.
Sector
Industry
Website
Headquarters
Tosu
Founded
1944
IPO date
Sep 1, 1962
Identifiers
2
ISIN JP3784600003
Hisamitsu Pharmaceutical Co., Inc. engages in the research, development, manufacture, and sale of pharmaceuticals and related products. Its products are sold under Salonpas, Salonsip, Mohrus, ByeBye-Fever, and Keplat brands. It also provides ethical pharmaceuticals, over- the-counter drugs, medical devices, health supplements, and topical analgesic products. The company was founded by Nihei Hisamitsu in 1847 and is headquartered in Tosu, Japan.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HPX is 33.20 EUR — it has decreased by −2.35% in the past 24 hours. Watch Hisamitsu Pharmaceutical Co., Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Hisamitsu Pharmaceutical Co., Inc. stocks are traded under the ticker HPX.
HPX stock has fallen by −0.60% compared to the previous week, the month change is a −1.19% fall, over the last year Hisamitsu Pharmaceutical Co., Inc. has showed a 29.69% increase.
HPX stock is 2.41% volatile and has beta coefficient of 0.54. Track Hisamitsu Pharmaceutical Co., Inc. stock price on the chart and check out the list of the most volatile stocks — is Hisamitsu Pharmaceutical Co., Inc. there?
Today Hisamitsu Pharmaceutical Co., Inc. has the market capitalization of 2.44 B, it has increased by 0.85% over the last week.
Yes, you can track Hisamitsu Pharmaceutical Co., Inc. financials in yearly and quarterly reports right on TradingView.
Hisamitsu Pharmaceutical Co., Inc. is going to release the next earnings report on Apr 9, 2026. Keep track of upcoming events with our Earnings Calendar.
HPX net income for the last quarter is 26.88 M EUR, while the quarter before that showed 25.94 M EUR of net income which accounts for 3.61% change. Track more Hisamitsu Pharmaceutical Co., Inc. financial stats to get the full picture.
Hisamitsu Pharmaceutical Co., Inc. dividend yield was 2.13% in 2024, and payout ratio reached 30.45%. The year before the numbers were 2.19% and 46.80% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has 2.8 K employees. See our rating of the largest employees — is Hisamitsu Pharmaceutical Co., Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hisamitsu Pharmaceutical Co., Inc. EBITDA is 139.97 M EUR, and current EBITDA margin is 16.17%. See more stats in Hisamitsu Pharmaceutical Co., Inc. financial statements.
Like other stocks, HPX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hisamitsu Pharmaceutical Co., Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hisamitsu Pharmaceutical Co., Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hisamitsu Pharmaceutical Co., Inc. stock shows the buy signal. See more of Hisamitsu Pharmaceutical Co., Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.